VG Med WF 135876 lungs middle lobe lingula segmental airways cylindrical bronchiectasis Lady Windermere syndrome MAC CT lungs middle lobe lingula segmental airways cylindrical bronchiectasis Lady Windermere syndrome MAC CT 61-year-old male with a history of treated mycobacterial infections including MAC present with chronic cough
<
<
Lary Windermere Syndrome
1. Challenge
Martin Ma, MS4 Ashley Davidoff MD
61-year-old male with a history of treated mycobacterial infections including MAC present with chronic cough
Axial CT: Lady Windermere Syndrome 61 y/o male with treated MAC and chronic cough. Axial CT shows mild cylindrical bronchiectasis (teal arrowheads), significant saccular bronchiectasis/bronchiolectasis in the middle lobe/lingula (yellow arrowheads), and a focus of tree-in-bud nodularity (white ring). The findings are characteristic of Lady Windermere syndrome. Ashley Davidoff MD TheCommonVein.net 250Lu 135876cL
Finding
Definition
Comment
Cylindrical Bronchiectasis
Also called tubular bronchiectasis; most common type.
Irreversible, uniform bronchial dilation, losing normal tapering.
Imaging shows “tram tracks” (longitudinal) or a “signet ring sign” (cross-section).
Characteristic CT finding in nodular bronchiectatic MAC, often in elderly women affecting the right middle lobe/lingula.
Pathogenesis involves chronic inflammation and bronchial wall damage from the infection.
Bilateral bronchiectasis with centrilobular nodules on CT strongly suggests NTM infection like MAC.
Jeong YJ, Radiology, 2004.
Bronchiolectasis
Irreversible dilation of bronchioles (small airways).
Caused by fibrosis or inflammatory airway diseases.
Appears as centrilobular nodules or “tree-in-bud” on CT when filled with mucus/pus.
Key feature in nodular-bronchiectatic MAC lung disease.
Occurs as inflammation extends to smaller airways.
The combination of bronchiectasis and bronchiolectasis strongly suggests MAC infection.
Hwang JH, AJR, 2002.
Tree-in-Bud Sign
CT finding implying small airway impaction.
Appears as centrilobular nodules with branching lines, like a budding tree.
Caused by fluid-filled bronchioles and thickened walls.
Common in mycobacterial infections (TB and MAC).
In Lady Windermere syndrome, it signifies active small airway inflammation.
The combination with bronchiectasis in the middle lobe/lingula is highly characteristic of MAC.
This clinical perspective focuses on the diagnosis and management of Lady Windermere Syndrome.
Definition
Lady Windermere syndrome refers to a specific presentation of pulmonary disease caused by Mycobacterium avium complex (MAC).
It classically describes an infection in the middle lobe and/or lingula in patients, often older women, without pre-existing lung disease or significant immunodeficiency.
The term is now often used interchangeably with the nodular bronchiectatic form of MAC lung disease.
Cause
The causative agent is the Mycobacterium avium complex (MAC), a group of nontuberculous mycobacteria (NTM) that includes species like M. avium and M. intracellulare.
These organisms are ubiquitous environmental saprophytes, commonly found in soil, dust, and water systems, including household water and shower aerosols.
Infection occurs through inhalation of aerosolized particles from the environment.
Person-to-person transmission is not considered a significant route of infection.
Pathophysiology
The pathophysiology is considered multifactorial, involving an interplay between the host, the bacterium, and airway mechanics.
It is hypothesized that a “two-hit” model is required: environmental exposure to NTM coupled with a host predisposition.
Host factors may include subtle immunodeficiencies, such as defects in the interferon-gamma/interleukin-12 signaling pathway or dysregulated T-helper cell responses.
Anatomic and phenotypic predispositions are also recognized, including slender body habitus, scoliosis, pectus excavatum, and mitral valve prolapse, which may lead to less effective cough mechanics and impaired mucociliary clearance.
The original hypothesis suggested that voluntary cough suppression led to secretion stasis, creating a nidus for infection, particularly in the gravitationally dependent right middle lobe and lingula.
Chronic inflammation from the MAC infection leads to the formation of granulomas and nodules, which in turn damages the bronchial walls, causing them to dilate and become bronchiectatic.
This structural damage further impairs mucociliary function, creating a cycle of mucus stasis and persistent infection.
Structural result
The primary structural consequence is the development of nodular bronchiectasis.
This involves irreversible cylindrical or varicose dilatation of the bronchi, predominantly affecting the right middle lobe and lingula.
The chronic inflammation and infection result in bronchial wall thickening, scarring, and the formation of centrilobular nodules and “tree-in-bud” opacities.
Over time, this can lead to progressive scarring, volume loss, and, in some cases, the formation of cavities.
Functional impact
The damaged, dilated airways have diminished mucociliary clearance, leading to the accumulation of secretions and recurrent infections.
This results in chronic airway inflammation and obstruction.
Clinically, patients present with symptoms such as a persistent productive cough, fatigue, weight loss, and sometimes dyspnea and hemoptysis.
Progressive disease can lead to a decline in overall lung function and significant morbidity.
Imaging
High-resolution computed tomography (HRCT) is the primary imaging modality for diagnosis and assessment.
The characteristic findings include multifocal bronchiectasis, which may be cylindrical or varicose, and is most prominent in the right middle lobe and lingula.
Associated findings include small centrilobular nodules, branching linear opacities creating a “tree-in-bud” appearance, and bronchial wall thickening.
Over time, serial imaging may demonstrate disease progression, with an increase in the extent of bronchiectasis and nodules.
Labs
The definitive diagnosis requires microbiological confirmation according to the American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) guidelines.
This typically involves positive culture results for MAC from at least two separate expectorated sputum samples or from at least one bronchial wash or lavage.
Alternatively, a diagnosis can be made from a lung biopsy showing mycobacterial histologic features (such as granulomatous inflammation) along with a positive culture from sputum, bronchial washing, or the tissue itself.
Acid-fast bacilli (AFB) smear may be negative, but cultures will eventually grow the organism.
Gene sequencing methods are used for precise species-level identification of the nontuberculous mycobacterium.
Treatment
The decision to treat is based on the severity of symptoms, evidence of radiographic progression, and patient-specific factors.
When treatment is indicated, the 2020 ATS/IDSA guidelines recommend a multi-drug, macrolide-based regimen.
For noncavitary nodular bronchiectatic disease, a three-times-weekly regimen of a macrolide (azithromycin or clarithromycin), ethambutol, and rifampin is suggested.
For severe or cavitary disease, a daily regimen is recommended.
Treatment duration is extensive, typically continuing for at least 12 months after the patient achieves sputum culture conversion.
Adjunctive therapies include airway clearance techniques.
Surgical resection of the most affected lobe or segment may be considered for patients with focal disease who fail medical therapy or have recurrent hemoptysis.
Prognosis
The natural course of nodular bronchiectatic MAC lung disease is variable.
Some patients remain stable for years without therapy, while others experience radiologic and clinical progression.
Untreated, a significant portion of patients show disease progression on serial CT scans over long-term follow-up.
With appropriate antibiotic therapy, sputum culture conversion is achieved in the majority of patients (around 95%).
Radiologic findings related to active inflammation can significantly improve.
However, the treatment is long and can be associated with significant drug toxicities.
Recurrence after completion of therapy can occur, and the underlying bronchiectasis is a permanent structural change.
The term “Lady Windermere syndrome” was coined in 1992 by Reich and Johnson. It is named after the titular character in Oscar Wilde’s 1892 play, *Lady Windermere’s Fan*. The authors hypothesized that the “fastidious” and “genteel” nature of the Victorian-era character, who might suppress a cough for social propriety, was analogous to the proposed mechanism in their patients.
AKA / Terminology
Nodular bronchiectatic form/bronchiectatic form (non-classic infection)
Nodular bronchiectasis
Historical Notes
In 1987, Prince first described a clinical syndrome of *Mycobacterium avium* complex (MAC) pulmonary disease in elderly, non-immunocompromised women who did not have pre-existing lung disease.
Previously, MAC pulmonary disease was primarily associated with elderly white men with underlying conditions like COPD or in immunocompromised individuals.
In 1992, physicians J.M. Reich and R.E. Johnson published a case series describing six elderly women with MAC pulmonary infection localized to the right middle lobe or lingula, who had no prior lung disease. They proposed the term “Lady Windermere syndrome” and hypothesized that habitual, voluntary cough suppression led to retained secretions in these anatomically susceptible lung regions, creating a nidus for infection.
The nodular and bronchiectatic features of this form of MAC lung disease became more widely appreciated with the advent and use of high-resolution computed tomography (CT) scans.
While the initial theory pointed to cough suppression, this has been debated, and other hypotheses suggest a link to connective tissue disorders or specific skeletal phenotypes (e.g., pectus excavatum, scoliosis).
Cultural or Practice Insights
The initial naming of the syndrome was rooted in a cultural stereotype of “fastidious” or “proper” elderly women who would avoid coughing in public. This reflects a historical, and likely inaccurate, perception linking behavior and social manners to disease pathogenesis.
Lady Windermere Syndrome:
The condition is noted to be more common in women than men, particularly middle-aged and older women with a thin body habitus.
There is a recognized challenge in diagnosing non-tuberculous mycobacterial (NTM) infections because the symptoms can be nonspecific and overlap with other chronic respiratory diseases like asthma or COPD. This can lead to delays in diagnosis.
Cultural and linguistic barriers can impact how patients with chronic respiratory diseases engage with healthcare, affecting self-management and understanding of their condition. Patients from diverse backgrounds may feel isolated if there is a lack of cultural representation among healthcare professionals.
Globally, community perceptions of respiratory infections can be a blend of biomedical understanding (person-to-person transmission) and traditional beliefs (imbalances of hot/cold).
Chronic cough is a significant symptom that has a substantial impact on quality of life, leading to the establishment of World Chronic Cough Day on October 15th to raise awareness.
Notable Figures or Contributions
J.M. Reich and R.E. Johnson: These physicians are credited with coining the term “Lady Windermere syndrome” in their seminal 1992 paper published in *Chest*. Their work identified a distinct clinical and radiographic pattern of MAC disease in a specific patient demographic.
Oscar Wilde: The Irish poet and playwright who wrote *Lady Windermere’s Fan*, the 1892 play from which the syndrome’s name is derived. The play is a satirical comedy of manners that explores the rigid moral codes of Victorian high society.
Ironmouse: A prominent Puerto Rican-American VTuber and singer who has raised significant public awareness about living with Common Variable Immunodeficiency (CVID) and a resulting *Mycobacterium avium* complex lung infection. She has fundraised for the Immune Deficiency Foundation and uses her platform to advocate for patients with similar conditions.
Quotes and/or Teaching Lines
“We offer the term, Lady Windermere’s syndrome, to describe this pattern among elderly women and to suggest that their fastidiousness may be its root cause.” – J.M. Reich & R.E. Johnson, *Chest*, 1992.
“We are all in the gutter, but some of us are looking at the stars.” – A famous line from Oscar Wilde’s play, *Lady Windermere’s Fan*, spoken by the character Lord Darlington, which speaks to finding hope amidst dire circumstances.
“It is absurd to divide people into good and bad. People are either charming or tedious.” – Another quote from *Lady Windermere’s Fan*, reflecting the play’s critique of simplistic moral judgments, a theme ironically echoed in the initial “fastidious” characterization of patients with the syndrome.
Painting
“The Lady with the Fan” (1862) by Édouard Manet: While not directly related to the syndrome, this painting captures the essence of a fashionable, poised woman of the era, reminiscent of the societal image that inspired the syndrome’s name. The fan is a central object, a tool of social grace and hidden expression.
Literature
Lady Windermere’s Fan (1892) by Oscar Wilde: The direct literary source for the syndrome’s name. The play is a comedy of manners about a woman who suspects her husband of infidelity and nearly leaves him, only to be saved by the very woman she despises, who is secretly her mother. The themes of social reputation, secrets, and strict moral codes are central.
Poetry
“Ode to a Nightingale” by John Keats: This poem explores themes of mortality, suffering, and the desire to escape the pain of human life (“The weariness, the fever, and the fret”). Keats himself suffered from tuberculosis, and the poem reflects a deep awareness of the fragility of health and the burden of disease.
Song/Music
“Carry On” by Ironmouse (2024): A single released by the VTuber Ironmouse, who lives with MAC lung infection. The song was featured in the documentary “Compromised: Life Without Immunity” by the Immune Deficiency Foundation, directly connecting artistic expression with patient advocacy for this condition.
A Quiet Lingering Guest
In bronchioles, a quiet, lingering guest, Where tapered airways put coughs to the test. A shadow gathers, a mycobacterial haze, In the middle lobe’s dependent, winding ways.
Named for a lady of Victorian stage, Whose gentle manners would her cough assuage. A fan conceals what society forbids, As bronchiectasis in the silence bids.
The tree-in-bud, a pattern on the screen, A fragile branching, where the foe convenes. A chronic siege, in breath both short and deep, While Wilde’s sharp wit, its secrets tries to keep.
1. Which of the following components is a unique and critical part of the *Mycobacterium avium* complex (MAC) cell wall, contributing significantly to its environmental resistance and virulence?
A. Lipopolysaccharide (LPS) B. Glycopeptidolipids (GPLs) C. Peptidoglycan D. Teichoic acid
2. The host’s primary and most critical immune response for controlling nontuberculous mycobacterial (NTM) infections, including MAC, is mediated by which of the following pathways?
A. Humoral immunity via antibody production B. The IL-12/IFN-γ axis C. Complement cascade activation D. Eosinophil degranulation
3. While named “Lady Windermere syndrome,” the nodular bronchiectatic form of MAC lung disease can occur in men. What is the classic phenotype described for this syndrome?
A. Young, obese males with a history of smoking B. Slender, post-menopausal, non-smoking females C. Middle-aged men with chronic obstructive pulmonary disease (COPD) D. Immunocompromised patients with low CD4 counts
4. According to the American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA) guidelines, what is the standard-of-care, three-drug regimen for the initial treatment of nodular bronchiectatic MAC pulmonary disease in a non-HIV patient?
A. Isoniazid, Rifampin, Pyrazinamide B. Azithromycin (or Clarithromycin), Rifampin, and Ethambutol C. Vancomycin, Piperacillin-tazobactam, and Gentamicin D. Doxycycline, Ceftriaxone, and Metronidazole
5. In addition to cylindrical bronchiectasis of the right middle lobe and lingula, which of the following is the most characteristic and common co-finding on high-resolution computed tomography (HRCT) in patients with the nodular bronchiectatic form of MAC lung disease?
A. Large, thick-walled cavitary lesions in the apices B. Diffuse ground-glass opacities with septal thickening C. Centrilobular nodules and tree-in-bud opacities D. Pleural plaques and effusions
6. The “tree-in-bud” sign on HRCT is highly suggestive of disease in which anatomical location?
A. Interlobular septa B. Small airways (bronchioles) C. Alveolar spaces D. Peribronchovascular interstitium
7. While characteristically associated with MAC infection, bronchiectasis predominantly involving the middle lobe and lingula can be seen in other conditions. Which of the following is a key differential diagnosis?
A. Primary ciliary dyskinesia B. Langerhans cell histiocytosis C. Silicosis D. Sarcoidosis
Part B
1. Which of the following components is a unique and critical part of the *Mycobacterium avium* complex (MAC) cell wall, contributing significantly to its environmental resistance and virulence?
A. Lipopolysaccharide (LPS)
x
LPS is a major component of the outer membrane of Gram-negative bacteria.
Mycobacteria are acid-fast bacilli and do not have an LPS-containing outer membrane.
B. Glycopeptidolipids (GPLs)
✓
The *M. avium* cell wall has a unique outer layer containing serovar-specific glycopeptidolipids (ssGPLs).
These GPLs are crucial for the organism’s virulence, biofilm formation, and intrinsic resistance to antimicrobials.
Jassal MS, J Bacteriol, 2001
C. Peptidoglycan
x
Peptidoglycan is a fundamental component of nearly all bacterial cell walls, including mycobacteria, but it is not unique to MAC.
D. Teichoic acid
x
Teichoic acids are found in the cell wall of most Gram-positive bacteria but are not a feature of the mycobacterial cell envelope.
2. The host’s primary and most critical immune response for controlling nontuberculous mycobacterial (NTM) infections, including MAC, is mediated by which of the following pathways?
A. Humoral immunity via antibody production
x
Defense against intracellular pathogens like mycobacteria is primarily cell-mediated, not humoral (antibody-based).
B. The IL-12/IFN-γ axis
✓
Control of mycobacteria relies on a robust Th1-type cell-mediated response.
Macrophages produce Interleukin-12 (IL-12), stimulating T-cells/NK cells to produce Interferon-gamma (IFN-γ).
IFN-γ activates macrophages to kill the intracellular mycobacteria.
Genetic defects in this pathway are linked to severe NTM disease.
Jouanguy E, N Engl J Med, 1996
C. Complement cascade activation
x
The complement system is not the primary mechanism for controlling and eradicating established NTM infection, which requires intracellular killing.
D. Eosinophil degranulation
x
Eosinophils are primarily associated with defense against parasitic infections and allergic reactions, not mycobacteria.
3. While named “Lady Windermere syndrome,” the nodular bronchiectatic form of MAC lung disease can occur in men. What is the classic phenotype described for this syndrome?
A. Young, obese males with a history of smoking
x
This phenotype is not characteristic of Lady Windermere syndrome.
B. Slender, post-menopausal, non-smoking females
✓
The classic description is of elderly, slender, white, post-menopausal women who are non-smokers without prior significant lung disease.
The name alludes to a character with a hypothesized link to voluntary cough suppression.
Reich JM, Chest, 1992
C. Middle-aged men with chronic obstructive pulmonary disease (COPD)
x
This phenotype is more classically associated with the upper-lobe fibrocavitary form of MAC disease, not the nodular bronchiectatic form.
D. Immunocompromised patients with low CD4 counts
x
Disseminated MAC infection is seen in advanced HIV/AIDS, but Lady Windermere syndrome specifically refers to a presentation in immunocompetent individuals.
4. According to the American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA) guidelines, what is the standard-of-care, three-drug regimen for the initial treatment of nodular bronchiectatic MAC pulmonary disease in a non-HIV patient?
A. Isoniazid, Rifampin, Pyrazinamide
x
This is the standard regimen for treating drug-susceptible *Mycobacterium tuberculosis*, not MAC.
B. Azithromycin (or Clarithromycin), Rifampin, and Ethambutol
✓
The ATS/IDSA guidelines recommend a macrolide-based, three-drug regimen for nodular/bronchiectatic MAC lung disease.
This combination is the cornerstone of therapy, often given three times weekly for non-cavitary disease.
Daley CL, Clin Infect Dis, 2020
C. Vancomycin, Piperacillin-tazobactam, and Gentamicin
x
This is broad-spectrum antibacterial coverage for severe nosocomial infections, not standard therapy for MAC.
D. Doxycycline, Ceftriaxone, and Metronidazole
x
This combination is used for various bacterial infections but has no primary role in treating MAC pulmonary disease.
5. In addition to cylindrical bronchiectasis of the right middle lobe and lingula, which of the following is the most characteristic and common co-finding on high-resolution computed tomography (HRCT) in patients with the nodular bronchiectatic form of MAC lung disease?
A. Large, thick-walled cavitary lesions in the apices
x
Apical fibrocavitary disease is the hallmark of the ‘classic’ form of NTM infection, distinct from the nodular bronchiectatic form.
B. Diffuse ground-glass opacities with septal thickening
x
This ‘crazy-paving’ pattern is characteristic of other conditions like pulmonary alveolar proteinosis, not typically MAC.
C. Centrilobular nodules and tree-in-bud opacities
✓
The nodular bronchiectatic form of MAC is defined by bronchiectasis (often RML/lingula) accompanied by small centrilobular nodules and the ‘tree-in-bud’ sign.
These findings represent bronchiolar inflammation and impaction.
Fujita J, Br J Radiol, 2003
D. Pleural plaques and effusions
x
Pleural plaques are most commonly associated with asbestos exposure.
Pleural effusions are not a specific or characteristic feature of this form of MAC.
6. The “tree-in-bud” sign on HRCT is highly suggestive of disease in which anatomical location?
A. Interlobular septa
x
Thickening of the interlobular septa results in a different pattern seen in conditions like pulmonary edema.
B. Small airways (bronchioles)
✓
The tree-in-bud pattern is a direct visualization of diseased small airways.
It is caused by the filling of centrilobular bronchioles with mucus, pus, or fluid, creating a branching appearance.
Collins J, Radiographics, 1996
C. Alveolar spaces
x
Filling of the alveolar spaces results in consolidation or ground-glass opacity, not a tree-in-bud pattern.
D. Peribronchovascular interstitium
x
Thickening here leads to peribronchial cuffing, which is distinct from the peripheral tree-in-bud pattern.
7. While characteristically associated with MAC infection, bronchiectasis predominantly involving the middle lobe and lingula can be seen in other conditions. Which of the following is a key differential diagnosis?
A. Primary ciliary dyskinesia
✓
Primary ciliary dyskinesia (PCD) is a genetic disorder of cilia that impairs mucociliary clearance.
This leads to chronic sinopulmonary infections and bronchiectasis, which can have a middle and lower lobe predominance.
Kennedy MP, Lancet, 2007
B. Langerhans cell histiocytosis
x
This disease is characterized by bizarrely shaped cysts and nodules with a strong upper lobe predominance.
C. Silicosis
x
Silicosis features multiple small nodules with an upper lobe predominance, not primarily middle lobe/lingular bronchiectasis.
D. Sarcoidosis
x
Sarcoidosis typically presents with perilymphatic nodules and hilar lymphadenopathy; bronchiectasis distribution is different.
Lady Windermere Syndrome: A Memory Image This AI-assisted memory image, styled after a Victorian-era painting, depicts two elderly women having high tea in a parlor. The subjects are portrayed as fastidious, delicately covering their mouths to voluntarily suppress a chronic cough, creating a visual metaphor for the syndrome’s namesake. This artwork illustrates the clinical concept of Lady Windermere syndrome, which describes a form of pulmonary Mycobacterium avium complex (MAC) disease typically seen in elderly, non-smoking women without prior lung disease. The term, derived from Oscar Wilde’s character, was coined to describe a patient profile of fastidious individuals who habitually suppress the cough reflex, leading to impaired mucus clearance. This stasis is thought to predispose the right middle lobe and lingula to indolent infection and subsequent bronchiectasis. (Reich, Chest 1992 — https://pubmed.ncbi.nlm.nih.gov/1541148/) Lady Windermere syndrome provides a memorable link between a behavioral trait—voluntary cough suppression—and a specific clinico-radiological pattern of MAC infection. Ashley Davidoff MD, AI-assisted — Memory Image – TheCommonVein.com (140583.MAD lungs Lady Windermere)
In Whispers Soft
In whispers soft, the cough suppressed, A silent battle in the chest. Like Lady Windermere’s poised refrain, Concealing all, enduring pain. The lungs, they yearn to be set free, From chains of silent propriety. In shadows deep, the truth does lie, A breath, a sigh, beneath the sky.
